Hospital Prof. Dr. Fernando Fonseca; Servico de Neurologia

Amadora 2720-276

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Multiple Sclerosis, Primary Progressive

Studies at this site

• Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). — Stopped early